Analysis of VEGF–VEGFR2 Binding Kinetics Using Surface Plasmon Resonance

JS John Schmidt
ML Min Kyung Lee
EK Eunkyung Ko
JJ Jae Hyun Jeong
LD Luisa A. DiPietro
HK Hyunjoon Kong
ask Ask a question
Favorite

A gold sensor chip (GE Healthcare, USA) was modified to present an 11-mercaptoundecanoic acid (MUA, Aldrich) monolayer by injecting MUA solution into the flow cell in a Biacore 3000 (GE Healthcare, USA) for 30 min at 25 °C. The carboxylic groups of the MUA monolayer were then activated by flowing 0.2 M EDC and 0.05 M N-hydroxysuccinimide (NHS, Aldrich) solutions through the flow cell for 7 min. After activation, 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE, Sigma) was chemically linked to the MUA layer by flowing DPPE solution until the response unit was saturated. The remaining NHS-ester groups on the MUA surface were blocked by injecting 1.0 M ethanolamine hydrochloride into the flow cell. Then the top layer was built by injecting a solution of recombinant human VEGFR-2 for 5 min. Finally, the mixture of VEGF and alginate sulfates or unmodified alginate suspended in PBS at a concentration of 2 μg/mL were injected into the flow cell to examine the association and dissociation rates of the VEGF complex with the gold sensor chip modified with DPPC and VEGFR-2. The media flow rate was kept constant at 5.0 μL/min. The kinetic data from SPR sensorgrams were obtained with the assistance of BIA evaluation version 4.1, where a 1:1 Langmuir binding model was applied to quantify the association and dissociation rates.23

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A